Search alternatives:
significant point » significant amount (Expand Search), significant part (Expand Search), significant event (Expand Search)
point decrease » point increase (Expand Search)
co decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 1 - 20 results of 5,647 for search '(( significant point decrease ) OR ( significant ((co decrease) OR (mean decrease)) ))', query time: 0.54s Refine Results
  1. 1
    IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1.

    IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    IRE1 depletion decreases heterochromatin, DNA, and H3K9me3 methylation, and UHRF1.

    IRE1 depletion decreases heterochromatin, DNA, and H3K9me3 methylation, and UHRF1. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Mean (95% CI) and standard deviation of Co-Contraction index of right and left gluteus medius (MVC%) during 60 minutes standing between two groups.

    Mean (95% CI) and standard deviation of Co-Contraction index of right and left gluteus medius (MVC%) during 60 minutes standing between two groups. by Saeedeh Abbasi (9423189)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Mean (95% CI) and standard deviation of Lumbar Lordosis angle(˚) between two groups pre and post 60 minutes of standing.

    Mean (95% CI) and standard deviation of Lumbar Lordosis angle(˚) between two groups pre and post 60 minutes of standing. by Saeedeh Abbasi (9423189)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Mean (95% CI) and standard deviation of VAS Score (mm) before & after intervention between two group during 1-houre standing. Intervention: using footrest with/without changing arm position.

    Mean (95% CI) and standard deviation of VAS Score (mm) before & after intervention between two group during 1-houre standing. Intervention: using footrest with/without changing arm... by Saeedeh Abbasi (9423189)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session.

    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Madrasin decreases transcription of protein-coding genes.

    Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

    Published 2024
    Save to List
    Saved in:
  8. 8
    ONSD modifications induced by arterial paCO<sub>2</sub> changes.

    ONSD modifications induced by arterial paCO<sub>2</sub> changes. by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 9
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 10
    Middle cerebral artery mean flow velocity at three time points.

    Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 11
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: